- The Dispatch @ DiscussPharma
- Posts
- U.S. biotech startups may IPO in Hong Kong π
U.S. biotech startups may IPO in Hong Kong π
How salad became a major source of food poisoning in the U.S., a deep dive into how scientists can repurpose a bacterial immune system to alter DNA and other interesting reads from the past week.
Noteworthy π°
China reverses course on cancer drug import tax. Link
Bill Gates to donate $12 million to develop a universal flu vaccine. Link
Takeda inches closer to scooping up Shire. Link
U.S. biotech startups may IPO in Hong Kong. Link
East Africa unveils a plan to bridge drugs manufacturing gap. Link
Digital Health π»
FDA expands its AI, digital health push. Link
Novartis keeps the focus on digital with eye disease app. Link
Research π¬
44 genetic risk factors for depression. Link
Drinking baking soda could be an inexpensive, safe way to combat autoimmune disease. Link
Perspective and Opinions π’
How high drug prices and big lobbying budgets go together for big pharma. Link
Even clinical trials can be fake now β hereβs how to spot one. Link
Why itβs so hard for doctors to understand your pain. Link
Interesting π€
How salad became a major source of food poisoning in the US. Link
Drinking alcohol may change the bacteria in your mouth. Link
Mosquitoes kill more people in a day than sharks do in a century. Link
Startups of the Week π°
Corvidia Therapeutics is a clinical stage biotechnology company pioneering the next generation of cardiovascular and cardio-renal therapies. Closed a $60m Series B funding round.
Rallybio develops innovative drug candidates against mechanisms that have biological rationales focusing on antibodies, small molecules and engineered proteins. Secured $37m in Series A funding.
EryDel develops an innovative red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Raised β¬26.5M in financing.
NuProbe is advancing an ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases. Raised $11m in Series A funding.
Deep Dive π
How scientists can repurpose a bacterial immune system to alter DNA, making everything from cheap insulin to extra starchy corn.